Literature DB >> 959114

Host defence mechanisms against influenza infection. II. Protection of mice with vaccines against A/Port Chalmers/1/73 and B/Hong Kong/5/72.

F A Ennis, M A Wells, D W Barry, S Daniel, J Manischewitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 959114      PMCID： PMC2496327          DOI： 10.1136/pgmj.52.608.338

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  9 in total

1.  Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.

Authors:  D W Barry; E Staton; R E Mayner
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

2.  The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses.

Authors:  D Hobson; R L Curry; A S Beare; A Ward-Gardner
Journal:  J Hyg (Lond)       Date:  1972-12

3.  Influenza immunization. A new vaccine.

Authors:  H A Cromwell; F B Brandon; I W McLean; J F Sadusk
Journal:  JAMA       Date:  1969-11-24       Impact factor: 56.272

4.  Antigenic enhancement of ether-extracted influenza virus vaccines by AIPO4.

Authors:  F M Davenport
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

5.  Purification of large quantities of influenza virus by density gradient centrifugation.

Authors:  C B Reimer; R S Baker; R M Van Frank; T E Newlin; G B Cline; N G Anderson
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

6.  Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants.

Authors:  P F Wright; S H Sell; J Thompson; D T Karzon
Journal:  J Pediatr       Date:  1976-01       Impact factor: 4.406

7.  Reactions and serologic responses in young children and infants after administration of inactivated monovalent influenza A vaccine.

Authors:  W M Marine; C Stuart-Harris
Journal:  J Pediatr       Date:  1976-01       Impact factor: 4.406

8.  Problems of influenza virus vaccine standardization.

Authors:  N M Tauraso; T C O'Brien; E B Seligman
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

9.  QUANTITATIVE RELATIONSHIPS BETWEEN THE IMMUNIZING DOSE OF EPIDEMIC INFLUENZA VIRUS AND THE RESULTANT IMMUNITY.

Authors:  T Francis
Journal:  J Exp Med       Date:  1939-01-31       Impact factor: 14.307
  9 in total
  5 in total

1.  Antibody production and protection against influenza virus in immunodeficient mice.

Authors:  S J Lucas; D W Barry; P Kind
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

Review 2.  Some newly recognized aspects of resistance against and recovery from influenza.

Authors:  A Ennis
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice.

Authors:  C McLaren; G E Grubbs; E Staton; W Barthlow; G Quinnan; F A Ennis
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

4.  Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro.

Authors:  M A Wells; P Albrecht; S Daniel; F A Ennis
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

5.  Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG.

Authors:  H P Taylor; N J Dimmock
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.